Gossamer Bio Inc. (GOSS) NASDAQ
$7.45 -0.01 (-0.13%)
Market Cap: $575.29M
As of 05/25/22 04:00 PM EDT. Market closed.
Gossamer Bio Inc. (GOSS) NASDAQ
$7.45 -0.01 (-0.13%)
Market Cap: $575.29M
As of 05/25/22 04:00 PM EDT. Market closed.
Gossamer Bio is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology. Its goal is to be an industry leader in each of these therapeutic areas and to enhance and extend the lives of patients suffering from such ... read more
Gossamer Bio is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology. Its goal is to be an industry leader in each of these therapeutic areas and to enhance and extend the lives of patients suffering from such diseases. read less
COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Sheila Gujrathi
Full Time Employees
196
CEO Compensation (Base)
$469,601
CEO Compensation (Total)
$18.71M
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Sheila Gujrathi
Full Time Employees
196
CEO Compensation (Base)
$469,601
CEO Compensation (Total)
$18.71M
URL
Address
3013 Science Park Rd, California, San Diego, 92121-1101.
PRICE CHART
From:
To:
KEY STATS
Open
$7.41
Previous Close
$7.46
Days Range
$7.17 - $7.56
52 week range
$6.28 - $14.30
Volume
491,294
Avg. Volume (30 days)
1,064,638
Market Cap
$575.29M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
77,116,705
Open
$7.41
Previous Close
$7.46
Days Range
$7.17 - $7.56
52 week range
$6.28 - $14.30
Volume
491,294
Avg. Volume (30 days)
1,064,638
Market Cap
$575.29M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
77,116,705
Open in:
Open in:
INSIDER TRANSACTIONS FOR GOSSAMER BIO INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Carter Laura | Chief Scientific Officer | May 04, 2022 | Sale | $7.20 | 1,262 | 9,086 | 89,042 | May 05, 2022, 06:14 PM |
| Christian Waage | EVP, Tech Ops and Admin | Mar 23, 2022 | Sale | $8.91 | 10,722 | 95,587 | 579,008 | Mar 24, 2022, 04:57 PM |
| Hasnain Faheem | President & CEO | Mar 23, 2022 | Sale | $8.91 | 19,035 | 169,697 | 143,465 | Mar 24, 2022, 04:55 PM |
| Giraudo Bryan | COO/CFO | Mar 23, 2022 | Sale | $8.91 | 10,722 | 95,587 | 99,167 | Mar 24, 2022, 04:53 PM |
| Carter Laura | Chief Scientific Officer | Mar 16, 2022 | Sale | $8.28 | 5,002 | 41,407 | 90,304 | Mar 17, 2022, 05:03 PM |
| Peterson Caryn | EVP, Regulatory Affairs | Mar 16, 2022 | Sale | $8.28 | 6,279 | 51,978 | 66,172 | Mar 17, 2022, 05:00 PM |
| Aranda Richard | Chief Medical Officer | Mar 16, 2022 | Sale | $8.28 | 6,278 | 51,976 | 211,675 | Mar 17, 2022, 04:58 PM |
| Peterson Caryn | EVP, Regulatory Affairs | Oct 25, 2021 | Sale | $12.25 | 2,377 | 29,118 | 72,451 | Oct 26, 2021, 05:08 PM |
| Carter Laura | Chief Scientific Officer | Oct 25, 2021 | Sale | $12.25 | 2,377 | 29,118 | 95,306 | Oct 26, 2021, 05:01 PM |
| Aranda Richard | Chief Medical Officer | Oct 25, 2021 | Sale | $12.25 | 2,377 | 29,118 | 217,432 | Oct 26, 2021, 04:58 PM |
| Salter-Cid Luisa | Chief Scientific Officer | Mar 23, 2021 | Sale | $9.48 | 5,491 | 52,052 | 206,065 | Mar 25, 2021, 04:13 PM |
| Giraudo Bryan | Chief Financial Officer | Mar 23, 2021 | Sale | $9.48 | 5,490 | 52,046 | 109,889 | Mar 25, 2021, 04:11 PM |
| Christian Waage | EVP & General Counsel | Mar 23, 2021 | Sale | $9.48 | 5,490 | 52,051 | 588,199 | Mar 25, 2021, 04:09 PM |
| Christian Waage | EVP & General Counsel | Oct 14, 2020 | Buy | $9.53 | 2,500 | 23,818 | 6,954 | Oct 14, 2020, 07:29 PM |
| Hasnain Faheem | Director | Oct 14, 2020 | Buy | $10.36 | 96,520 | 999,995 | 3,478,629 | Oct 14, 2020, 07:28 PM |
| Giraudo Bryan | Chief Financial Officer | Oct 14, 2020 | Buy | $10.01 | 3,000 | 30,036 | 7,121 | Oct 14, 2020, 07:27 PM |
| Giraudo Bryan | Chief Financial Officer | Jun 23, 2020 | Buy | $12.96 | 2,000 | 25,922 | 4,121 | Jun 23, 2020, 05:01 PM |
| Dupont Jakob | Chief Medical Officer | Dec 30, 2019 | Option Exercise | $10.71 | 40,000 | 428,400 | 40,000 | Dec 31, 2019, 05:00 PM |
| Dupont Jakob | Chief Medical Officer | Dec 27, 2019 | Option Exercise | $10.71 | 1,994 | 21,356 | 1,994 | Dec 31, 2019, 05:00 PM |
| Dupont Jakob | Chief Medical Officer | Dec 30, 2019 | Sale | $15.00 | 40,000 | 600,004 | 0 | Dec 31, 2019, 05:00 PM |
| Dupont Jakob | Chief Medical Officer | Dec 27, 2019 | Sale | $15.81 | 1,994 | 31,534 | 0 | Dec 31, 2019, 05:00 PM |
| Christian Waage | EVP & General Counsel | Sep 27, 2019 | Buy | $16.65 | 1,000 | 16,654 | 4,454 | Sep 27, 2019, 10:46 AM |
| Hasnain Faheem | Director | Sep 27, 2019 | Buy | $16.80 | 10,000 | 167,980 | 3,382,109 | Sep 27, 2019, 10:41 AM |
| Gujrathi Sheila | President & CEO | Sep 27, 2019 | Buy | $16.80 | 10,000 | 167,980 | 4,048,242 | Sep 27, 2019, 10:39 AM |
| Giraudo Bryan | Chief Financial Officer | Sep 26, 2019 | Buy | $16.78 | 1,121 | 18,810 | 2,121 | Sep 26, 2019, 04:08 PM |
| Omega Fund V, L.P. | 10% Owner | Sep 20, 2019 | Sale | $21.96 | 183,607 | 4,032,560 | 6,553,416 | Sep 23, 2019, 03:51 PM |
| Omega Fund V, L.P. | 10% Owner | Sep 18, 2019 | Sale | $21.88 | 45,600 | 997,637 | 6,737,023 | Sep 18, 2019, 06:28 PM |
| Omega Fund V, L.P. | 10% Owner | Sep 17, 2019 | Sale | $21.61 | 23,400 | 505,791 | 6,782,623 | Sep 18, 2019, 06:28 PM |
| Omega Fund V, L.P. | 10% Owner | Sep 16, 2019 | Sale | $21.52 | 13,213 | 284,331 | 6,806,023 | Sep 18, 2019, 06:28 PM |
| Omega Fund V, L.P. | 10% Owner | Sep 11, 2019 | Sale | $21.31 | 80,403 | 1,713,629 | 6,819,236 | Sep 12, 2019, 07:41 PM |
| Omega Fund V, L.P. | 10% Owner | Sep 10, 2019 | Sale | $21.00 | 32,373 | 679,865 | 6,899,639 | Sep 12, 2019, 07:41 PM |
| Omega Fund V, L.P. | 10% Owner | Sep 05, 2019 | Sale | $21.60 | 12,704 | 274,434 | 6,940,712 | Sep 09, 2019, 05:37 PM |
| Omega Fund V, L.P. | 10% Owner | Sep 06, 2019 | Sale | $21.51 | 8,700 | 187,103 | 6,932,012 | Sep 09, 2019, 05:37 PM |
| Salter-Cid Luisa | Chief Scientific Officer | Aug 29, 2019 | Sale | $20.09 | 26,252 | 527,319 | 124,056 | Aug 29, 2019, 06:26 PM |
| Salter-Cid Luisa | Chief Scientific Officer | Aug 28, 2019 | Sale | $19.65 | 23,748 | 466,724 | 150,308 | Aug 29, 2019, 06:26 PM |
| Giraudo Bryan | Chief Financial Officer | May 30, 2019 | Buy | $18.70 | 1,000 | 18,700 | 1,000 | Jun 03, 2019, 04:03 PM |
| Cox Russell J. | Director | Feb 12, 2019 | Buy | $16.00 | 7,200 | 115,200 | 7,200 | Feb 12, 2019, 05:40 PM |
| Christian Waage | EVP & General Counsel | Feb 12, 2019 | Buy | $16.00 | 1,550 | 24,800 | 501,498 | Feb 12, 2019, 05:36 PM |
| Giraudo Bryan | Chief Financial Officer | Feb 12, 2019 | Buy | $16.00 | 6,000 | 96,000 | 23,879 | Feb 12, 2019, 05:33 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Carter Laura | Chief Scientific Officer | 05/04/2022 | 9,086 |
| Christian Waage | EVP, Tech Ops and Admin | 03/23/2022 | 95,587 |
| Hasnain Faheem | President & CEO | 03/23/2022 | 169,697 |
| Giraudo Bryan | COO/CFO | 03/23/2022 | 95,587 |
| Carter Laura | Chief Scientific Officer | 03/16/2022 | 41,407 |
| Peterson Caryn | EVP, Regulatory Affairs | 03/16/2022 | 51,978 |
| Aranda Richard | Chief Medical Officer | 03/16/2022 | 51,976 |
| Peterson Caryn | EVP, Regulatory Affairs | 10/25/2021 | 29,118 |
| Carter Laura | Chief Scientific Officer | 10/25/2021 | 29,118 |
| Aranda Richard | Chief Medical Officer | 10/25/2021 | 29,118 |
| Salter-Cid Luisa | Chief Scientific Officer | 03/23/2021 | 52,052 |
| Giraudo Bryan | Chief Financial Officer | 03/23/2021 | 52,046 |
| Christian Waage | EVP & General Counsel | 03/23/2021 | 52,051 |
| Christian Waage | EVP & General Counsel | 10/14/2020 | 23,818 |
| Hasnain Faheem | Director | 10/14/2020 | 999,995 |
| Giraudo Bryan | Chief Financial Officer | 10/14/2020 | 30,036 |
| Giraudo Bryan | Chief Financial Officer | 06/23/2020 | 25,922 |
| Dupont Jakob | Chief Medical Officer | 12/30/2019 | 428,400 |
| Dupont Jakob | Chief Medical Officer | 12/27/2019 | 21,356 |
| Dupont Jakob | Chief Medical Officer | 12/30/2019 | 600,004 |
| Dupont Jakob | Chief Medical Officer | 12/27/2019 | 31,534 |
| Christian Waage | EVP & General Counsel | 09/27/2019 | 16,654 |
| Hasnain Faheem | Director | 09/27/2019 | 167,980 |
| Gujrathi Sheila | President & CEO | 09/27/2019 | 167,980 |
| Giraudo Bryan | Chief Financial Officer | 09/26/2019 | 18,810 |
| Omega Fund V, L.P. | 10% Owner | 09/20/2019 | 4,032,560 |
| Omega Fund V, L.P. | 10% Owner | 09/18/2019 | 997,637 |
| Omega Fund V, L.P. | 10% Owner | 09/17/2019 | 505,791 |
| Omega Fund V, L.P. | 10% Owner | 09/16/2019 | 284,331 |
| Omega Fund V, L.P. | 10% Owner | 09/11/2019 | 1,713,629 |
| Omega Fund V, L.P. | 10% Owner | 09/10/2019 | 679,865 |
| Omega Fund V, L.P. | 10% Owner | 09/05/2019 | 274,434 |
| Omega Fund V, L.P. | 10% Owner | 09/06/2019 | 187,103 |
| Salter-Cid Luisa | Chief Scientific Officer | 08/29/2019 | 527,319 |
| Salter-Cid Luisa | Chief Scientific Officer | 08/28/2019 | 466,724 |
| Giraudo Bryan | Chief Financial Officer | 05/30/2019 | 18,700 |
| Cox Russell J. | Director | 02/12/2019 | 115,200 |
| Christian Waage | EVP & General Counsel | 02/12/2019 | 24,800 |
| Giraudo Bryan | Chief Financial Officer | 02/12/2019 | 96,000 |
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2021
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
06/30/2021
0.62%
2Q
03/31/2021
1.01%
3Q
12/31/2020
9.24%
4Q
09/30/2020
11.82%
5Q
06/30/2020
16.50%
6Q
03/31/2020
20.93%
7Q
12/31/2019
36.72%
8Q
Load More